BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22825572)

  • 1. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
    Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
    Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
    Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
    Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
    Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
    Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.
    Bai Y; Gou M; Yi T; Yang L; Liu L; Lin X; Su D; Wei Y; Zhao X
    Int J Med Sci; 2015; 12(5):397-406. PubMed ID: 26005374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.
    Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X
    Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
    Xie C; Gou ML; Yi T; Deng H; Li ZY; Liu P; Qi XR; He X; Wei Y; Zhao X
    Hum Gene Ther; 2011 Nov; 22(11):1413-22. PubMed ID: 21513424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor effect of biodegradable cationic heparin-polyethyleneimine nanogels delivering FILIP1LΔC103 gene combined with low-dose cisplatin on ovarian cancer.
    Xie C; Gou M; Yi T; Qi X; Liu P; Wei Y; Zhao X
    Oncotarget; 2017 Sep; 8(44):76432-76442. PubMed ID: 29100323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral vectors modified by heparin-polyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo.
    Wei W; Mu Y; Li X; Gou M; Zhang H; Luo S; Men K; Mao Y; Qian Z; Yang L
    J Biomed Nanotechnol; 2011 Dec; 7(6):768-75. PubMed ID: 22416575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis.
    Zhou X; Li X; Gou M; Qiu J; Li J; Yu C; Zhang Y; Zhang N; Teng X; Chen Z; Luo C; Wang Z; Liu X; Shen G; Yang L; Qian Z; Wei Y; Li J
    Cancer Sci; 2011 Jul; 102(7):1403-9. PubMed ID: 21564417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of PLGA nanoparticles encapsulating the human PNAS-4 gene combined with cisplatin in ovarian cancer.
    Qi X; Song X; Liu P; Yi T; Li S; Xie C; Zheng Y; Bai Y; Sun C; Wei Y; Zhao X
    Oncol Rep; 2011 Sep; 26(3):703-10. PubMed ID: 21667029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
    Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine.
    Gou M; Men K; Zhang J; Li Y; Song J; Luo S; Shi H; Wen Y; Guo G; Huang M; Zhao X; Qian Z; Wei Y
    ACS Nano; 2010 Oct; 4(10):5573-84. PubMed ID: 20839784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W; Liang B; Yin J; Li X; Cheng J
    Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma.
    Liu Y; Chen L; He X; Fan L; Yang G; Chen X; Lin X; DU L; Li Z; Ye H; Mao Y; Zhao X; Wei Y
    Int J Gynecol Cancer; 2008; 18(4):652-9. PubMed ID: 17892458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
    Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
    Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model.
    Mabuchi S; Terai Y; Morishige K; Tanabe-Kimura A; Sasaki H; Kanemura M; Tsunetoh S; Tanaka Y; Sakata M; Burger RA; Kimura T; Ohmichi M
    Clin Cancer Res; 2008 Dec; 14(23):7781-9. PubMed ID: 19047105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enhancement of antitumor effect of cisplatin on human ovarian cancer by cyclosporin A in vitro and in vivo].
    Zhou Y; Chen H; Yang Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):25-8. PubMed ID: 8758815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.
    Staub J; Chien J; Pan Y; Qian X; Narita K; Aletti G; Scheerer M; Roberts LR; Molina J; Shridhar V
    Oncogene; 2007 Jul; 26(34):4969-78. PubMed ID: 17310998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.
    Luo L; Du T; Zhang J; Zhao W; Cheng H; Yang Y; Wu Y; Wang C; Men K; Gou M
    Int J Nanomedicine; 2016; 11():501-12. PubMed ID: 26893558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.